Bixiye
QP45-23 Expansion of SmartChoice Program for Fully Insured Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Natiijooyinka Raadinta
Soo bandhiga 1631 - 1640 ee natiijooyinka 4139
Bixiye
QP46-23 Clarification to Preventive Visit Reimbursement Policy (Bulletin P19-23)
Taariikhda uu dhaqangalayo Barnaamijka: May 24, 2023
Bixiye
QP36-23 Eligibility Redeterminations for Minnesota Health Care Programs Members
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP37-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP38-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP39-23 Commercial Pharmacy Benefit Exclusion for Lamzede®
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP40-23 MHCP Pharmacy Benefit Exclusion for Lamzede® and Zynyz™
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP41-23 Makena® (hydroxyprogesterone caproate): Drug Approval Withdrawn
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023